ATE324450T1 - Polypeptid, das neutralisierende antikörper gegen hiv induziert - Google Patents
Polypeptid, das neutralisierende antikörper gegen hiv induziertInfo
- Publication number
- ATE324450T1 ATE324450T1 AT02710945T AT02710945T ATE324450T1 AT E324450 T1 ATE324450 T1 AT E324450T1 AT 02710945 T AT02710945 T AT 02710945T AT 02710945 T AT02710945 T AT 02710945T AT E324450 T1 ATE324450 T1 AT E324450T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- antibodies against
- neutralizing antibodies
- against hiv
- induces neutralizing
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000003472 neutralizing effect Effects 0.000 title 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0100141A FR2819256B1 (fr) | 2001-01-05 | 2001-01-05 | Polypeptide induisant des anticorps neutralisant le vih |
| FR0100848 | 2001-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE324450T1 true ATE324450T1 (de) | 2006-05-15 |
Family
ID=26212817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02710945T ATE324450T1 (de) | 2001-01-05 | 2002-01-04 | Polypeptid, das neutralisierende antikörper gegen hiv induziert |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1368478B1 (de) |
| AT (1) | ATE324450T1 (de) |
| AU (1) | AU2002229850A1 (de) |
| CA (1) | CA2431881C (de) |
| CY (1) | CY1105629T1 (de) |
| DE (1) | DE60210936T2 (de) |
| DK (1) | DK1368478T3 (de) |
| ES (1) | ES2260416T3 (de) |
| PT (1) | PT1368478E (de) |
| WO (1) | WO2002053587A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1445614A1 (de) | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Verfahren zur in vitro Überwachung der Entwicklung von HIV Virus eines Individuums |
| EP1466924B9 (de) * | 2003-04-11 | 2013-06-19 | Institut Pasteur | Synthetische Peptid-HIV-Vakzine: das CBD-Epitop als effizientes Immunogen zur Induktion HIV-neutralisierender Antikörper |
| CN1954217B (zh) * | 2004-02-06 | 2013-05-08 | 国立健康与医学研究所 | 衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途 |
| WO2014020205A2 (es) * | 2012-07-31 | 2014-02-06 | Universidad De Granada | Inmunógenos anti-vih mejorados |
| CN114605505B9 (zh) | 2018-08-09 | 2025-04-29 | 东莞市朋志生物科技有限公司 | 用于检测hiv-1的合成肽 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9912732A (pt) * | 1998-08-03 | 2001-11-27 | Univ Montana | Estrutura molecular isolada, vìrus envelopadorecombinante, formilação de vacina, anticorpomonoclonal, anti-soro policlonal, geléia, espuma,creme ou unguento contraceptivo, amostras desangue de mamìfero e de humano, kit, linhagemcelular, processos de tratamento ou deprevenção de infecção por um vìrus em sujeito, detratamento ou de prevenção de infecção por hivem um humano, de inibição de infecção por um vìrusem uma amostra de sangue, de inibição de infecçãopor hiv em uma amostra de sangue humano, dedescontaminação de ferramentas cirúrgicas oudentais, de monitoração de produto de anticorpopara a estrutura molecular, de produção de umimunógeno para uso em uma vacina para otratamento ou a prevenção de infecção por umvìrus, e de produção de um imunólogeno para usoem uma vacina para o tratamento ou a prevençãode infecção por hiv, estrutura reticulada,anticorpo monoclonal para a estrutura, dedescontaminação de ferramentas cirúrgicas oudentais, processo de seleção de uma estruturamolecular para eficácia de vacina, mamìfero,complexo de proteìna isolado, formulação devacina, processos de imunização de um animal paraum vìrus, e de preparação de um complexo deproteìna, células fixadas, processos depurificação de um complexo de proteìna e detratamento de um hospedeiro que tem sidoexposto a um vìrus, ou de prevenção de infecçãode um hospedeiro pelo citado vìrus, e composição. |
| JP2003529319A (ja) * | 1999-01-08 | 2003-10-07 | キャロル ディ. ウエイス, | HIV−1gp41を標的化する広範に中和する抗体を誘発する方法 |
-
2002
- 2002-01-04 CA CA2431881A patent/CA2431881C/en not_active Expired - Fee Related
- 2002-01-04 WO PCT/FR2002/000031 patent/WO2002053587A2/fr not_active Ceased
- 2002-01-04 AU AU2002229850A patent/AU2002229850A1/en not_active Abandoned
- 2002-01-04 DE DE60210936T patent/DE60210936T2/de not_active Expired - Lifetime
- 2002-01-04 AT AT02710945T patent/ATE324450T1/de active
- 2002-01-04 PT PT02710945T patent/PT1368478E/pt unknown
- 2002-01-04 EP EP02710945A patent/EP1368478B1/de not_active Expired - Lifetime
- 2002-01-04 ES ES02710945T patent/ES2260416T3/es not_active Expired - Lifetime
- 2002-01-04 DK DK02710945T patent/DK1368478T3/da active
-
2006
- 2006-06-28 CY CY20061100881T patent/CY1105629T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2260416T3 (es) | 2006-11-01 |
| DK1368478T3 (da) | 2006-08-28 |
| EP1368478A2 (de) | 2003-12-10 |
| AU2002229850A1 (en) | 2002-07-16 |
| DE60210936T2 (de) | 2006-10-19 |
| DE60210936D1 (de) | 2006-06-01 |
| CA2431881C (en) | 2011-02-22 |
| WO2002053587A3 (fr) | 2003-09-25 |
| PT1368478E (pt) | 2006-07-31 |
| CY1105629T1 (el) | 2010-12-22 |
| EP1368478B1 (de) | 2006-04-26 |
| CA2431881A1 (en) | 2002-07-11 |
| WO2002053587A2 (fr) | 2002-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0014282A (pt) | Vacinas | |
| MXPA02007478A (es) | Vacuna contra el virus de inmunodeficiencia humana. | |
| BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
| PL366579A1 (en) | Treatment of nail infections with no | |
| DE60125797D1 (de) | Impfstoffzusammesetzung | |
| ATE508735T1 (de) | Pulmonale verabreichung von aminoglykosiden | |
| CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
| DK1328547T3 (da) | Identifikation og modifikation af immundominante epitoper i polypeptider | |
| ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
| DE60239682D1 (de) | Vakzine, welche gp120 zusammen mit nef und/oder tat enthält, zur immunisierung gegen hiv | |
| DK1404367T3 (da) | Anvendelse af polyklonalt anti-HIV gedeserum som et terapeutisk middel | |
| YU68602A (sh) | Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje | |
| DE60210936D1 (de) | Polypeptid, das neutralisierende antikörper gegen hiv induziert | |
| BR0209145A (pt) | Vacina contra varìola | |
| DE69720065D1 (de) | Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen | |
| NO20032597D0 (no) | Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma | |
| WO2005089231A3 (en) | Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide | |
| CY1108852T1 (el) | Φυσικο αντισωμα ενepγο κατα του ιου hiv | |
| CY1106200T1 (el) | Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους | |
| TW200621800A (en) | Human immunodeficiency virus vaccine | |
| AU2003255866A8 (en) | Gp41 epitope and uses thereof for the treatment of hiv infections | |
| RU2001107405A (ru) | Способ повышения статокинетической устойчивости человека | |
| FR2819256B1 (fr) | Polypeptide induisant des anticorps neutralisant le vih | |
| FR2839721B1 (fr) | Antigene polypeptidique induisant des anticorps neutralisant le vih |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1368478 Country of ref document: EP |